Indrayani Biotech Ltd vs Meghna Infracon Infrastructure Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 21, 2026

Key Highlights

The Latest Trading Price of Indrayani Biotech Ltd is ₹ 12.18 as of 21 Apr 12:42 . The P/E Ratio of Indrayani Biotech Ltd changed from 23.5 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Meghna Infracon Infrastructure Ltd changed from 80.7 on March 2024 to 97.1 on March 2025 . This represents a CAGR of 9.69% over 2 years The Market Cap of Indrayani Biotech Ltd changed from ₹ 21.73 crore on March 2021 to ₹ 64.93 crore on March 2025 . This represents a CAGR of 24.47% over 5 yearsThe Market Cap of Meghna Infracon Infrastructure Ltd changed from ₹ 255.91 crore on March 2024 to ₹ 896 crore on March 2025 . This represents a CAGR of 87.12% over 2 years The revenue of Indrayani Biotech Ltd for the Dec '25 is ₹ 35.85 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -5.03% The revenue of Meghna Infracon Infrastructure Ltd for the Dec '25 is ₹ 8.51 crore as compare to the Sep '25 revenue of ₹ 8.77 crore. This represent the decline of -2.96% The ebitda of Indrayani Biotech Ltd for the Dec '25 is ₹ 3.62 crore as compare to the Sep '25 ebitda of ₹ 4.25 crore. This represent the decline of -14.82% The ebitda of Meghna Infracon Infrastructure Ltd for the Dec '25 is ₹ 4.12 crore as compare to the Sep '25 ebitda of ₹ 1.33 crore. This represent the growth of 209.77% The net profit of Indrayani Biotech Ltd changed from ₹ 0.85 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of -67.33% The net profit of Meghna Infracon Infrastructure Ltd changed from ₹ 1.78 crore to ₹ 1.1 crore over 7 quarters. This represents a CAGR of -24.05% The Dividend Payout of Indrayani Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Meghna Infracon Infrastructure Ltd changed from 3.43 % on March 2024 to 1.18 % on March 2025 . This represents a CAGR of -41.35% over 2 years .

About Indrayani Biotech Ltd

Indrayani Biotech Limited was incorporated in 1992.
The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds.
Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture.
The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95.

About Meghna Infracon Infrastructure Ltd

Meghna Infracon Infrastructure Limited was originally registered as 'Naysaa Securities Private Limited' on 19 October, 2007.
The Company status was converted into a Public Limited Company and the name was reflected as 'Naysaa Securities th Limited' vide fresh Certificate of Incorporation dated 5 February, 2014 issued by the Registrar of Companies, Mumbai, Maharashtra.
Further, the name was changed to Meghna Infracon Infrastructure Limited on November 17, 2023. The Company obtained Certificate of Registration from SEBI for conducting trading activities with Bombay Stock Exchange Limited for both Capital Market and Derivative Segments in October, 2010.
The Company BSE's main broker, involved in the activities like broking and investment advisory services in shares, securities and derivatives for the Indian Stock Market.

FAQs for the comparison of Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd

Which company has a larger market capitalization, Indrayani Biotech Ltd or Meghna Infracon Infrastructure Ltd?

Market cap of Indrayani Biotech Ltd is 55 Cr while Market cap of Meghna Infracon Infrastructure Ltd is 1,345 Cr

What are the key factors driving the stock performance of Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd?

The stock performance of Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd?

As of April 21, 2026, the Indrayani Biotech Ltd stock price is INR ₹12.08. On the other hand, Meghna Infracon Infrastructure Ltd stock price is INR ₹619.25.

How do dividend payouts of Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd compare?

To compare the dividend payouts of Indrayani Biotech Ltd and Meghna Infracon Infrastructure Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.